Analysis of anti-Mulerian hormone in premenopausal women with autoimmune diseases

Analysis of anti-Mulerian hormone in premenopausal women with autoimmune diseases - anti-Mulerian hormone in premenopausal women with autoimmune diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023157

Enrollment

150

Registered

2016-07-14

Start date

2016-01-05

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune diseases

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Premenopausal women with autoimmune diseases 2) Patients must be able to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients who refuse to participate this research 2) Patients for whom the physicians do not think suitable for this study

Design outcomes

Primary

Measure	Time frame
Comparison of anti-Mulerian hormone level in premenopausal women with autoimmune diseases	—

Secondary

Measure	Time frame
Comparison of anti-Mulerian hormone level between before and after treatment in premenopausal women with autoimmune diseases	—

Countries

Japan

Contacts

Public ContactHiroko Kanda

University of Tokyo Immune-mediated Diseases Therapy Center, Graduate School of Medicine

hkanda-tky@umin.ac.jp03-3815-5411

Outcome results